Estrogen receptor activation protects against TNF-α-induced endothelial dysfunction

Angiology

Volumn 65, Issue 1, 2014, Pages 17-21

  Palmieri, Daniela ^a   Perego, Patrizia ^b   Palombo, Domenico ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

apigenin; endothelial dysfunction; eNOS; estrogen receptor; MMP 9; TNF

Indexed keywords

A 3145; APIGENIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; G PROTEIN COUPLED RECEPTOR; GELATINASE B; P 7028; PERTUSSIS TOXIN; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR;

ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; ESTROGEN ACTIVITY; HORMONE RECEPTOR INTERACTION; CELL CULTURE TECHNIQUE; DRUG EFFECTS; ENZYMOLOGY; HUMAN; METABOLISM; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APIGENIN; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; ENDOTHELIUM, VASCULAR; HUMANS; MATRIX METALLOPROTEINASE 9; NITRIC OXIDE SYNTHASE TYPE III; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84888614583     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319713477909     Document Type: Article

References (25)

1. Gouva L, Tsatsoulis A. The role of estrogens in cardiovascular disease in the aftermath of clinical trials. Hormones. 2004 ; 3 (3). 171-183
2. Kolovou G, Giannakopoulou V, Vasiliadis Y, Bilianou H. Effects of estrogens on atherogenesis. Curr Vasc Pharmacol. 2011 ; 9 (2). 244-257
3. Meyer MR, Schurr U, Barton M.. Erα, Erβ, and gpER: novel aspects of oestrogen receptor signalling in atherosclerosis. Cardiovasc Res. 2009 ; 83 (4). 605-610
4. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signalling. Science. 2005 ; 307 (5715). 1625-1630
5. Losordo DW, Kearney M, Kim EA, Jekanowski J, Isner JM. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation. 1994 ; 89 (4). 1501-1510
6. Post WS, Goldschmidt-Clermont PJ, Wilhide CC, et al. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res. 1999 ; 43 (4). 985-991
7. Kim-Schultze S, McGowan KA, Hubchak SC, et al. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation. 1996 ; 94 (6). 1402-1407
8. Venkov CD, Rankin AB, Vaughan DE. Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. Circulation. 1996 ; 94 (4). 727-733
9. Vanhoutte PM, Shimokawa H, Tang EHC, Feletou M. Endothelial dysfunction and vascular disease. Acta Physiol. 2009 ; 196 (2). 193-222
10. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999 ; 340 (23). 1801-1811
11. Zhang H, Park Y, Wu J, et al. Role of TNF-α in vascular dysfunction. Clin Sci. 2009 ; 116 (3). 219-230
12. Palmieri D, Aliakbarian B, Casazza A, et al. Effects of polyphenols extract from olive pomace on anoxia induced endothelial dysfunction. Microvasc Res. 2012 ; 83 (3). 281-289
13. Palombo D, Maione M, Cifiello BI, Udini M, Maggio D, Lupo M.. Matrix metalloproteinases. Their role in degenerative chronic diseases of abdominal aorta. J Cardiovasc Surg. 1999 ; 40 (2). 257-260
14. Thompson RW, Parks WC. Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann N Y Acad Sci. 2006 ; 800: 157-174
15. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994 ; 94 (6). 2493-2503
16. Yang B, Rizzo V. TNFα potentiates protein-tyrosine nitration through activation of NADPH oxidase and eNOS localized in membrane raft and caveolae of bovine aortic endothelial cells. Am J Physiol Heart Circ Physiol. 2007 ; 292 (2). H954 - H962
17. Gao X, Xu X, Belmadani S, et al. TNF-α contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol. 2007 ; 27 (6). 1269-1275
18. Paik C, Ramey WG, Dillon J, Tilson MD. The nitrite/elastin reaction: implication for in vivo degenerative effects. Connect Tissue Res. 1997 ; 36 (3). 241-251
19. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. Reactive oxygen species produced by macrophages-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro: implication for atherosclerotic plaque stability. J Clin Invest. 1996 ; 98 (11). 2572-2579
20. Shiojima I, Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res. 2002 ; 90 (12). 1243-1250
21. Bersacchi R, Perrotta C, Bulotta S, Moncada S, Borghese N, Clementi E.. Activation of endothelial nitric-oxide synthase by tumor necrosis factor-α: a novel pathway involving sequential activation on neutral sphingomyelinase, phosphatidylinositol-3' kinase and Akt. Mol Pharmacol. 2003 ; 63 (4). 886-895
22. Benavente-Garca O, Castillo J. Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity. J Agric Food Chem. 2008 ; 56 (15). 6185-6205
23. Long X, Fan M, Bigsby RM, Nephew KP. Apigenin inhibits antiestrogen-resistant breast cancer cell growth through estrogen receptor-α-dependent and estrogen receptor-α-independent mechanisms. Mol Cancer Ther. 2008 ; 7 (7). 2096-2108
24. Mak P, Leung YK, Tang WY, Harwood C, Ho SM. Apigenin suppresses cancer cell growth through Erβ. Neoplasia. 2006 ; 8 (11). 896-904
25. Wang J, Liao Y, Fan J, Ye T, Sun X, Dong S.. Apigenin inhibits the expression of IL-6, IL-8 and ICAM-1 in DEHP-stimulated human umbilical vein endothelial cells and in vivo. Inflammation. 2012 ; 35 (4). 1466-1476